Galderma Announces Positive Data From Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Germany ,Taiwan ,Japan ,United States ,Switzerland ,Clin Pharmacol ,Christian Marcoux ,Rachel Mooney ,Tracy Krumme ,Chugai Pharmaceutical Co Ltd ,Corporate Communications ,Drug Administration ,Global Franchise Communications ,Breakthrough Therapy ,Injectable Aesthetics ,Rev Clin ,Business Wire ,Health ,Business ,